Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy
- PMID: 36232144
- PMCID: PMC9565127
- DOI: 10.3390/ijerph191912844
Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy
Abstract
Mortality related to chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic is possibly underestimated by sparse available data. The study aimed to assess the impact of the pandemic on COPD-related mortality by means of time series analyses of causes of death data. We analyzed the death certificates of residents in Veneto (Italy) aged ≥40 years from 2008 to 2020. The age-standardized rates were computed for COPD as the underlying cause of death (UCOD) and as any mention in death certificates (multiple cause of death-MCOD). The annual percent change (APC) in the rates was estimated for the pre-pandemic period. Excess COPD-related mortality in 2020 was estimated by means of Seasonal Autoregressive Integrated Moving Average models. Overall, COPD was mentioned in 7.2% (43,780) of all deaths. From 2008 to 2019, the APC for COPD-related mortality was -4.9% (95% CI -5.5%, -4.2%) in men and -3.1% in women (95% CI -3.8%, -2.5%). In 2020 compared to the 2018-2019 average, the number of deaths from COPD (UCOD) declined by 8%, while COPD-related deaths (MCOD) increased by 14% (95% CI 10-18%), with peaks corresponding to the COVID-19 epidemic waves. Time series analyses confirmed that in 2020, COPD-related mortality increased by 16%. Patients with COPD experienced significant excess mortality during the first year of the pandemic. The decline in COPD mortality as the UCOD is explained by COVID-19 acting as a competing cause, highlighting how an MCOD approach is needed.
Keywords: COVID-19; chronic obstructive pulmonary disease; mortality; multiple causes of death.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Mortality Related to Chronic Obstructive Pulmonary Disease and Co-morbidities in the United States, A Multiple Causes of Death Analysis.COPD. 2018 Apr;15(2):200-205. doi: 10.1080/15412555.2018.1454897. Epub 2018 Apr 26. COPD. 2018. PMID: 29697272
-
COPD-Related Mortality and Co-morbidities in Northeastern Italy, 2008-2012: A Multiple Causes of Death Analysis.COPD. 2016;13(1):35-41. doi: 10.3109/15412555.2015.1043427. Epub 2015 Sep 14. COPD. 2016. PMID: 26367073
-
Parkinson's disease related mortality: Long-term trends and impact of COVID-19 pandemic waves.Parkinsonism Relat Disord. 2022 May;98:75-77. doi: 10.1016/j.parkreldis.2022.04.011. Epub 2022 Apr 25. Parkinsonism Relat Disord. 2022. PMID: 35490543 Free PMC article.
-
Veneto Region dementia-related mortality during the COVID-19 pandemic: multiple causes of death and time series analysis.Eur J Public Health. 2023 Apr 1;33(2):190-195. doi: 10.1093/eurpub/ckad005. Eur J Public Health. 2023. PMID: 36847686 Free PMC article.
-
Increased Alcohol-Related Mortality in Wisconsin Pre-COVID: A Two-Decade Trend.WMJ. 2022 Dec;121(4):269-273. WMJ. 2022. PMID: 36637836 Review.
Cited by
-
Estimating Overall and Cause-Specific Excess Mortality during the COVID-19 Pandemic: Methodological Approaches Compared.Int J Environ Res Public Health. 2023 May 24;20(11):5941. doi: 10.3390/ijerph20115941. Int J Environ Res Public Health. 2023. PMID: 37297545 Free PMC article.
-
Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19.Infect Drug Resist. 2023 Dec 22;16:7797-7808. doi: 10.2147/IDR.S433186. eCollection 2023. Infect Drug Resist. 2023. PMID: 38148771 Free PMC article.
-
Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population Study.Ann Am Thorac Soc. 2024 Sep;21(9):1281-1288. doi: 10.1513/AnnalsATS.202312-1078OC. Ann Am Thorac Soc. 2024. PMID: 38820253 Free PMC article.
-
Unrecognised COVID-19 deaths in central Europe: The importance of cause-of-death certification for the COVID-19 burden assessment.PLoS One. 2024 Jul 16;19(7):e0307194. doi: 10.1371/journal.pone.0307194. eCollection 2024. PLoS One. 2024. PMID: 39012883 Free PMC article.
-
Sensitivity of major chronic diseases and patients of different ages to the collapse of the healthcare system during the COVID-19 pandemic in China.Medicine (Baltimore). 2024 Nov 29;103(48):e40730. doi: 10.1097/MD.0000000000040730. Medicine (Baltimore). 2024. PMID: 39612440 Free PMC article.
References
-
- Carlson S.A., Wheaton A.G., Watson K.B., Liu Y., Croft J.B., Greenlund K.J. Geographic Differences in Sex-Specific Chronic Obstructive Pulmonary Disease Mortality Rate Trends Among Adults Aged ≥ 25 Years—United States, 1999–2019. MMWR Morb/ Mortal Wkly. Rep. 2022;71:613–618. doi: 10.15585/mmwr.mm7118a1. - DOI - PMC - PubMed
-
- GBD 2015 Chronic Respiratory Disease Collaborators Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 2017;5:691–706. doi: 10.1016/S2213-2600(17)30293-X. - DOI - PMC - PubMed
-
- Chronic Obstructive Pulmonary Disease (COPD) [(accessed on 31 August 2022)]. Available online: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...
MeSH terms
LinkOut - more resources
Full Text Sources
Medical